66
Views
63
CrossRef citations to date
0
Altmetric
Research Article

Nitroglycerin in the Treatment of Cocaine Associated Chest Pain — Clinical Safety and Efficacy

, , , , , , , , , , & show all
Pages 243-256 | Published online: 25 Sep 2008

References

  • National Institute of Drug Abuse. National household survey on drug abuse. Population estimates,1991. 1992, Revised Nov., 1992, DHHS Publication No. (ADM) 92-1887
  • Cregler L, Mark L. H. Relation of acute myocardial infarction to cocaine abuse. Am J Cardiol 1985; 56: 794
  • Goldfrank L R, Hoffman R S. The cardiovascular effects of cocaine. Ann Emerg Med 1991; 20: 165–175
  • Coleman D L, Ross T F, Naughton J L. Myocardial ischemia and infarction related to recreational cocaine use. West J Med 1982; 136: 444–446
  • Hollander J E, Hoffman R S. Cocaine induced myocardial infarction: An analysis and review of the literature. J Emerg Med 1992; 10: 169–177
  • Minor R L, Scott B D, Brown D D, Winniford M D. Cocaine-induced myocardial infarction in patients with normal coronary arteries. Ann Intern Med 1991; 115: 797–806
  • Brody S L, Slovis C M, Wrenn K D. Cocaine-related medical problems: Consecutive series of 233 patients. Am J Med 1990; 88: 325–331
  • Zimmerman J L, Dellinger R P, Majid P A. Cocaine associated chest pain. Ann Emerg Med 1991; 20: 611–615
  • Gitter M J, Goldsmith S R, Dunbar D N, Sharkey S W. Cocaine and chest pain: Clinical features and outcome of patients hospitalized to rule out myocardial infarction. Ann Intern Med 1991; 115: 277–282
  • Amin M, Gabelman G, Karpel J, Buttrick P. Acute myocardial infarction and chest pain syndromes after cocaine use. Am J Cardiol 1990; 66: 1434–1437
  • Tokarski G F, Paganussi P, Urbanski R, et al. An evaluation of cocaine induced chest pain. Ann Emerg Med 1990; 19: 1088–1092
  • Hollander J E, Hoffman R S, Gennis P, et al. Prospective multicenter evaluation of cocaine associated chest pain. Academic Emergency Medicine 1994; 1(4), in press
  • Catravas J D, Waters I W. Acute cocaine intoxication in the conscious dog: studies on the mechanism of lethality. J Pharmacol Exp Therap 1981; 217: 350–356
  • Guinn M M, Bedford J A, Wilson M C. Antagonism of intravenous cocaine lethality in nonhuman primates. Clin Toxicol 1980; 16: 499–508
  • Lange R A, Cigarroa R G, Yancy C W, et al. Cocaine induced coronary-artery vasoconstriction. N Engl J Med 1989; 321: 1557–1562
  • Lange R A, Cigarroa R G, Flores E D, et al. Potentiation of cocaine induced coronary vasoconstriction by beta-adrenergic blockade. Ann Intern Med 1990; 112: 897–903
  • Eichhorn E J, Peacock E, Grayburn P A, et al. Chronic cocaine abuse in association with accelerated atherosclerosis in human coronary arteries. J Am Coll Cardiol 1992; 19: 105A
  • Brickner M E, Willard J E, Eichhorn E J, Black J, Grayburn P A. Left ventricular hypertrophy associated with chronic cocaine abuse. Circulation 1991; 84: 1130–1135
  • Zimmerman F H, Gustafson G M, Kemp H G. Recurrent myocardial infarction associated with cocaine abuse in a young man with normal coronary arteries: Evidence for coronary artery spasm culminating in thrombosis. J Am Coll Cardiol 1987; 9: 964–968
  • Ascher E K, Stauffer J C, Gaasch W H. Coronary artery spasm, cardiac arrest, transient electrocardiographic Q waves and stunned myocardium in cocaine-associated acute myocardial infarction. Am J Cardiol 1988; 61: 939–941
  • Hollander J E, Carter W A, Hoffman R S. Use of phentolamine for cocaine induced myocardial ischemia. N Engl J Med 1992; 327: 361
  • ISIS-1 (First International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous atenolol among 16,027 cases of suspected acute myocardial infarction: ISIS-1. Lancet 1986; 2: 57–66
  • The International Collaborative Study Group. Reduction of infarct size with the early use of timolol in acute myocardial infarction. N Engl J Med 1984; 310: 9–15
  • The MIAMI Trial Research Group. Metoprolol in acute myocardial infarction (MIAMI). A randomised placebo-controlled international trial. European Heart J 1985; 6: 199–226
  • Sand I C, Brody S L, Wrenn K D, Slovis C M. Experience with esmolol for the treatment of cocaine-associated cardiovascular complications. Am J Emerg Med 1991; 9: 161–163
  • Meredith I T, Anderson T J, Uehata A, Yeung A C, Selwyn A P, Ganz P. Role of endothelium in ischemic coronary syndromes. Am J Cardiol 1993; 72 Suppl: 27C–32C
  • Rutherford J D. Pharmacologic management of angina and acute myocardial infarction. Am J Cardiol 1993; 72 Suppl: 16C–20C
  • Jugdutt B I, Warnica J W. Intravenous nitroglycerin therapy to limit myocardial infarct size, expansion and complications: Effect of timing, dosage, and infarct location. Circulation 1988; 78: 906–919
  • Jaffe A S, Geltman E M, Tiefenbrunn A J, et al. Reduction of infarct size in patients with inferior infarction with intravenous glyceryl trinitrate. A randomised study. Br Heart J 1983; 49: 452–460
  • Bussmann W D, Passek D, Seidel W, Kaltenbach M. Reduction of CK and CK-MB indexes of infarct size by intravenous nitroglycerin. Circulation 1981; 63: 615–622
  • Yusuf S, Collins R, MacMahon S, Peto R. Effect of intravenous nitrates on mortality in acute myocardial infarction: An overview of the randomised trials. Lancet 1988; 1: 1088–1092
  • Brogan W C, Lange R A, Kim A S, Moliterno D J, Hillis L D. Alleviation of cocaine-induced coronary vasoconstriction by nitroglycerin. J Am Coll Cardiol 1991; 18: 581–586
  • Togna G, Tempesta E, Togna A R, et al. Platelet responsiveness and biosynthesis of thromboxane and prostacyclin in response to in-vitro cocaine treatment. Haemostasis 1985; 15: 100–107
  • Schnetzer G W. Platelets and thrombogenesis - current concepts. Am Heart J 1972; 83: 552–564
  • Rezkalla S H, Mazza J J, Kloner R A, Tillema V, Chang S H. Effects of cocaine on human platelets in healthy subjects. Am J Cardiol 1993; 72: 243–246
  • Gerlach H, Esposito C, Stern D M. Modulation of endothelial hemostatic properties: an active role in the host response. Annu Rev Med 1990; 41: 15–24
  • Bassenge E. Antiplatelet effects of endothellum-derived relaxing factor and nitric oxide donors. Eur Heart J 1991; 12 suppl E: 12–15
  • Moncada S, Gryglewski R, Bunting S, Vane J R. An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature 1976; 263: 663–665
  • Busse R, Luckhoff A, Bassenge E. Endothelium derived relaxant factor inhibits platelet activation. Naunyn-Schmiedebergs Arch Pharmacol 1987; 336: 566–571
  • Hogan J C, Lewis M J, Henderson A H. In vivo EDRF activity influences platelet function. Br J Pharmacol 1988; 94: 1020–1022
  • Radomski M W, Palmer R M, Moncada S. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet 1987; 2: 1057–1058
  • Parker J O. Nitrates and angina pectoris. Am J Cardiol 1993; 72: 3C–8C
  • Ferguson J J, Diver D J, Boldt M, Pasternak R C. Significance of nitroglycerin-induced hypotension with inferior wall acute myocardial infarction. Am J Cardiol 1989; 64: 311–314

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.